Correlation Between Memscap Regpt and Sartorius Stedim

Can any of the company-specific risk be diversified away by investing in both Memscap Regpt and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memscap Regpt and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Memscap Regpt and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Memscap Regpt and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memscap Regpt with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memscap Regpt and Sartorius Stedim.

Diversification Opportunities for Memscap Regpt and Sartorius Stedim

-0.02

Correlation Coefficient

Memscap Regpt  Sartorius Stedim

Good diversification

The 3 months correlation between Memscap and Sartorius is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Memscap Regpt and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Memscap Regpt is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memscap Regpt are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Memscap Regpt i.e., Memscap Regpt and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Memscap Regpt and Sartorius Stedim

Assuming the 90 days trading horizon Memscap Regpt is expected to generate 1.24 times more return on investment than Sartorius Stedim. However, Memscap Regpt is 1.24 times more volatile than Sartorius Stedim Biotech. It trades about 0.0 of its potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about -0.02 per unit of risk. If you would invest  381.00  in Memscap Regpt on August 31, 2024 and sell it today you would lose (75.00) from holding Memscap Regpt or give up 19.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Memscap Regpt  vs.  Sartorius Stedim Biotech

Memscap Regpt

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Memscap Regpt has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Sartorius Stedim Biotech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Memscap Regpt and Sartorius Stedim

The main advantage of trading using opposite Memscap Regpt and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memscap Regpt position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.

The idea behind Memscap Regpt and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.